Idioma:

The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France

Dimeglio, Chloé ; Loubes, Jean-Michel ; Deporte, Benjamin ; Dubois, Martine ; Latour, Justine ; Mansuy, Jean-Michel ; Izopet, Jacques

The Journal of infection, 2020-08, Vol.81 (2), p.318-356 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por

Enviar para

Título:
The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France
Autor: Dimeglio, Chloé ; Loubes, Jean-Michel ; Deporte, Benjamin ; Dubois, Martine ; Latour, Justine ; Mansuy, Jean-Michel ; Izopet, Jacques
Assuntos: Betacoronavirus ; Coronavirus Infections - epidemiology ; Coronavirus Infections - prevention & control ; Coronavirus Infections - transmission ; COVID-19 ; deconfinement ; France - epidemiology ; Human health and pathology ; Humans ; Infection Control - methods ; Infectious diseases ; Letter to the Editor ; Life Sciences ; Models, Statistical ; Pandemics - prevention & control ; Pandemics - statistics & numerical data ; Pneumonia, Viral - epidemiology ; Pneumonia, Viral - prevention & control ; Pneumonia, Viral - transmission ; SARS-CoV-2 ; Seroepidemiologic Studies ; seroprevalence ; statistical model
É parte de: The Journal of infection, 2020-08, Vol.81 (2), p.318-356
Notas: SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
PMCID: PMC7189187
Descrição: •Failure to anticipate the spread of SARS-CoV-2 after the containment phase seriously threatens many health systems.•We have developed a method for measuring how seroprevalence affects the deconfinement strategy in France.•Seroprevalence must be at least 50% before confinement constraints can be relaxed.•Deconfinement should be progressive in order to avoid rebound of the epidemic. A new virus, SARS-CoV-2, has spread world-wide since December 2019, probably affecting millions of people and killing thousands. Failure to anticipate the spread of the virus now seriously threatens many health systems. We have designed a model for predicting the evolution of the SARS-CoV-2 epidemic in France, which is based on seroprevalence and makes it possible to anticipate the deconfinement strategy.
Editor: England: Elsevier Ltd
Idioma: Inglês

Links

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France

Dimeglio, Chloé ; Loubes, Jean-Michel ; Deporte, Benjamin ; Dubois, Martine ; Latour, Justine ; Mansuy, Jean-Michel ; Izopet, Jacques

England: Elsevier Ltd

Buscando em bases de dados remotas. Favor aguardar.